Virus News and Research

Latest Virus News and Research

Scientists discover mechanism by which E6 oncoprotein of high-risk HPV16 promotes carcinogenesis

In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.

4 Dec 2009

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

According to the World Health Organization, the human H1N1/09 Type A influenza ("Swine Flu") has reached a pandemic level. Over 500,000 cases have been confirmed worldwide with at least 6,500 fatalities. Since there is no longer a requirement to test and report individual cases, these numbers undoubtedly understate the real situation.

4 Dec 2009

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study

4 Dec 2009

New medical-scientific article on A/H1N1 epidemic

A special issue of Deutsches -rzteblatt International contains the first scientific presentation of clinical experience with the novel influenza A virus (H1N1/09) in the German-speaking countries since the start of the pandemic.

4 Dec 2009

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic.

4 Dec 2009

WHO investigates Tamiflu resistance, updates antiviral recommendations for H1N1 patients with severely compromised immune systems

Following recent reports of clusters of Tamiflu resistance, the WHO on Wednesday recommended that patients with severely weakened immune systems who become infected with the H1N1 (swine flu) virus receive additional antiviral treatment as needed throughout the duration of their illness, Agence France-Presse reports. "

4 Dec 2009

Opinions: Media coverage of HIV/AIDS; WTO and global health; G8, HIV/AIDS; stopping syringe reuse

In a New Republic/NPR opinion piece, Harold Pollack, an associate professor at the University of Chicago School of Social Service Administration, looks at the media's coverage of World AIDS Day. "Almost six thousand people died of AIDS [Tuesday]. ... That it happened to be World AIDS Day was almost incidental. AIDS was certainly incidental to much of the mainstream media.

4 Dec 2009

Also in global health news: U.S. aid to Philippines, Swaziland, Guyana; Uganda Bills; Botswana HIV/AIDS

U.S. Ambassador to the Philippines Kristie Kenney said the U.S. will give the country an additional $10 million worth of food aid for people affect by the recent typhoons, the Manila Bulletin reports. This brings "the total amount of its disaster relief and recovery assistance to US$30 million" (Sabater, 12/3).

3 Dec 2009

Fear of swine flu impacts lifestyle

One of the lasting legacies of 2009 and looming challenges of 2010 is the H1N1 virus. Fears about contracting H1N1 (commonly known as the swine flu) have consumed many Americans for most of the year, so EarnMyDegree.com (http://www.earnmydegree.com), a web resource of EducationDynamics, which connects prospective students with online classes, commissioned a new study about whether flu-related worries have caused people to change their habits.

3 Dec 2009

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

3 Dec 2009

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.

3 Dec 2009

Tripep receives approval to extend ChronVac-C study

Today Tripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one additional treatment with the therapeutic vaccine.

3 Dec 2009

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

The Roche assay for the 2009 H1N1 influenza virus detects RNA from the 2009 H1N1 Influenza A virus and provides a rapid means of identification of patients infected with this virus. In order to ensure continued specificity and sensitivity of the Roche's Influenza A/H1N1 assay, Roche performs sequence comparisons with all available 2009 H1N1 Influenza Virus sequences on a regular basis.

3 Dec 2009

Email security experts at Red Condor issue a warning about latest spam campaign

Email security experts at Red Condor today issued a warning about the latest spam campaign claiming to be from the Center for Disease Control and Prevention (CDC) and requesting that recipients complete a "Personal H1N1 Vaccination Profile."

3 Dec 2009

Roche ships additional quantities of Tamiflu oral suspension

Roche announced today that it has begun shipping additional quantities of Tamiflu® (oseltamivir phosphate) oral suspension (liquid).

3 Dec 2009

Respiratory syncytial virus, the most common cause of pneumonia in children

RSV is a respiratory virus that infects the lungs and breathing passages. While most healthy people recover from RSV infection, it can be severe in infants. According to the United States Centers for Disease Control and Prevention (CDC), RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year of age in the nation.

3 Dec 2009

Children vaccinated against chickenpox at much lower risk of developing shingles

Vaccination to prevent chickenpox (varicella) appears to have an added benefit for children—a reduced risk of shingles (herpes zoster). That's the finding of a study in the November issue of The Pediatric Infectious Disease Journal, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Dec 2009

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

The number of H1N1 (swine flu) cases in the U.S. appears to be decreasing, the CDC said Tuesday, CQ HealthBeat reports. "Flu was widespread in 32 states by the end of the week of Nov. 21, a decrease from 43 states in the prior week and 46 states earlier this fall, according to the CDC," the news service writes. "

3 Dec 2009

Leaders respond to World AIDS Day; South Africa to expand HIV treatment program

Marking World AIDS Day on Tuesday, U.N. Secretary General Ban Ki-Moon "warned ... that new infections are outpacing the gains from treating people with the HIV virus" and that discrimination against HIV-positive people remains "widespread," the Associated Press reports.

2 Dec 2009

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.

2 Dec 2009

Virus News and Research

Latest Virus News and Research

Scientists discover mechanism by which E6 oncoprotein of high-risk HPV16 promotes carcinogenesis

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

New medical-scientific article on A/H1N1 epidemic

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

WHO investigates Tamiflu resistance, updates antiviral recommendations for H1N1 patients with severely compromised immune systems

Opinions: Media coverage of HIV/AIDS; WTO and global health; G8, HIV/AIDS; stopping syringe reuse

Also in global health news: U.S. aid to Philippines, Swaziland, Guyana; Uganda Bills; Botswana HIV/AIDS

Fear of swine flu impacts lifestyle

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Tripep receives approval to extend ChronVac-C study

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

Email security experts at Red Condor issue a warning about latest spam campaign

Roche ships additional quantities of Tamiflu oral suspension

Respiratory syncytial virus, the most common cause of pneumonia in children

Children vaccinated against chickenpox at much lower risk of developing shingles

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

Leaders respond to World AIDS Day; South Africa to expand HIV treatment program

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in